Reza Khosravan

Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies

Nancy Cooper, Reza Khosravan, Carol Erdmann et al. · Journal of Chromatography B · 2006 · 199 citations

Medicine, Bioanalysis, Pharmacology +12

Pharmacokinetics and Pharmacodynamics of Febuxostat, a New Non-purine Selective Inhibitor of Xanthine Oxidase in Subjects with Renal Impairment

Michael D. Mayer, Reza Khosravan, Laurent Vernillet et al. · American Journal of Therapeutics · 2005 · 153 citations

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

Reza Khosravan, Brian Grabowski, Jingtao Wu et al. · Clinical Pharmacokinetics · 2006 · 104 citations

Healthy Subjects, Pharmacological Study, Pharmacology +6

Febuxostat (TMX‐67), a Novel, Non‐Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

Michael A. Becker, James C. Kisicki, Reza Khosravan et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 96 citations

Molecular Pharmacology, Adverse Events, Urology +15

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

Giuseppe Curigliano, Xavier Pivot, Javier Cortés et al. · The Breast · 2013 · 88 citations

Breast Oncology, Oncology, Cancer Management +6